Research Article
Characterization of the designer drug deschloroketamine (2‐methylamino‐2‐phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high‐resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance